FDA Approves EVOQUE Tricuspid Valve Replacement System for Tricuspid Regurgitation
The FDA approval of Edwards Lifesciences EVOQUE tricuspid valve replacement system for treatment of symptomatic severe tricuspid regurgitation is the first of its kind for a transcatheter therapy.
Source: hcplive.com